ALFA Finder| Revenue growth | Consolidated Q2 revenue +23% YoY to ₹76,149 mn |
|---|---|
| Margins | Healthcare EBITDA margin 24.0%, down 60bps; HealthCo 5.9% |
| Demand visibility | Inpatient volume +14%; established units occupancy 76% |
Growth
H1 FY27 revenue +22% to ₹145,468 mn; EBITDA +29%; PAT +33% to ₹12,106 mn. Healthcare EBITDA +20%.
Outlook
Expansion: 4,198 beds balance, ~₹7,100 cr capex; Q4 FY27 annualized target ₹250bn revenue, ₹15bn EBITDA.
Risks
HealthCo margin 5.9% amid manpower and one-time LTIP costs; Healthcare margin down 60bps; new hospital losses ₹348 mn.
Last quarter's promises, checked
Partly delivered
- Guided 620 beds activated over 12–18 mo → ~132 moved to operational (4,330→4,198 balance) (= PARTIAL; pace on track)
- Guided ~₹7,500 cr balance spend → ~₹7,100 cr remaining (= PARTIAL; ~₹400 cr deployed)
Investor Presentation filed with NSE, NSE: APOLLOHOSP. Summary written with AI assistance from the document.
Apollo Hospitals Enterprise Ltd: key numbers
- Share price
- ₹8,502.00
- Market cap
- ₹1,22,246 Cr
- Revenue (annual)
- ₹25,228 Cr
- Net profit (annual)
- ₹1,942 Cr
- P/E (TTM)
- 54.5×Sector 54.5×
- Promoter holding
- 28.02%+0.00% QoQ
- FII holding
- 43.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Apollo Hospitals Enterprise Ltd
All →Apollo Hospitals Enterprise Earnings Call Transcript: Key Takeaways
Consolidated Q2 revenue ₹7,615 Cr (+23%), EBITDA ₹1,191 Cr (+29%), margin 15.6% vs 14.9%. Growth is solid, but Apollo Health Co's FY27 margin outlook was trimmed and management avoided explicit hospital growth guidance.
Apollo Hospitals Enterprise Q2 FY27 Results: Net Profit ₹659.5 Cr, Up 33.5% YoY
Apollo Hospitals Enterprise Ltd reported revenue from operations of ₹7,615 Cr (+23.0% YoY) and net profit of ₹659.5 Cr (+33.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹659.5 Cr · +33.5% YoY
Apollo Hospitals Enterprise Board Meeting Date
Apollo Hospitals will hold a board meeting on 04 Nov 2026 to consider Q1 FY27 financial results. No financial figures are disclosed in this advance intimation.
Apollo Hospitals Enterprise Other Announcement
Apollo Hospitals Enterprise Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.
Apollo Hospitals Enterprise Share Pledge
Apollo Hospitals Enterprise promoter K Vishweshwar Reddy created a pledge on 200,000 equity shares worth ₹177.78 Crore. This transaction reflects a change in promoter encumbrance status.
- Value
- ₹177.8 Cr
Apollo Hospitals Enterprise Annual General Meeting
Apollo Hospitals Enterprise Limited conducted its 45th Annual General Meeting on August 25, 2026. The proceedings covered routine items and resolutions, including NCD issuance approval.